Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
Main Authors: | Hong-Joon Shin, Joon-Young Yoon, Young-Ok Na, Jae-Kyeong Lee, Bo Gun Kho, Tae-Ok Kim, Yu-Il Kim, Sung-Chul Lim, Sae-Hee Jeong, Yong-Soo Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653473/?tool=EBI |
Similar Items
-
Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.
by: Hong-Joon Shin, et al.
Published: (2023-01-01) -
Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis.
by: Tae-Ok Kim, et al.
Published: (2022-01-01) -
Hypersensitivity reactions to multiple anti-tuberculosis drugs.
by: Hong-Joon Shin, et al.
Published: (2021-01-01) -
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study.
by: Young-Ok Na, et al.
Published: (2022-01-01) -
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study
by: Young-Ok Na, et al.
Published: (2022-01-01)